Literature DB >> 33274546

Daily and intermittent smoking are associated with low prefrontal volume and low concentrations of prefrontal glutamate, creatine, myo-inositol, and N-acetylaspartate.

Paul Faulkner1,2, Susanna Lucini Paioni3, Petya Kozhuharova1, Natasza Orlov4, David J Lythgoe4, Yusuf Daniju1, Elenor Morgenroth1,2,5, Holly Barker1,2, Paul Allen1,2,6.   

Abstract

Cigarette smoking is still the largest contributor to disease and death worldwide. Successful cessation is hindered by decreases in prefrontal glutamate concentrations and gray matter volume due to daily smoking. Because nondaily, intermittent smoking also contributes greatly to disease and death, understanding whether infrequent tobacco use is associated with reductions in prefrontal glutamate concentrations and gray matter volume may aid public health. Eighty-five young participants (41 nonsmokers, 24 intermittent smokers, 20 daily smokers, mean age ~23 years old), underwent 1 H-magnetic resonance spectroscopy of the medial prefrontal cortex, as well as structural magnetic resonance imaging (MRI) to determine whole-brain gray matter volume. Compared with nonsmokers, both daily and intermittent smokers exhibited lower concentrations of glutamate, creatine, N-acetylaspartate, and myo-inositol in the medial prefrontal cortex, and lower gray matter volume in the right inferior frontal gyrus; these measures of prefrontal metabolites and structure did not differ between daily and intermittent smokers. Finally, medial prefrontal metabolite concentrations and right inferior frontal gray matter volume were positively correlated, but these relationships were not influenced by smoking status. This study provides the first evidence that both daily and intermittent smoking are associated with low concentrations of glutamate, creatine, N-acetylaspartate, and myo-inositol and low gray matter volume in the prefrontal cortex. Future tobacco cessation efforts should not ignore potential deleterious effects of intermittent smoking by considering only daily smokers. Finally, because low glutamate concentrations hinder cessation, treatments that can normalize tonic levels of prefrontal glutamate, such as N-acetylcysteine, may help intermittent and daily smokers to quit.
© 2020 Society for the Study of Addiction.

Entities:  

Keywords:  N-acetylaspartate; creatine; glutamate; gray matter; prefrontal; smoking

Mesh:

Substances:

Year:  2020        PMID: 33274546     DOI: 10.1111/adb.12986

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  3 in total

1.  Higher glutamatergic activity in the medial prefrontal cortex in chronic ketamine users.

Authors:  Qiuxia Wu; Jinsong Tang; Chang Qi; An Xie; Jianbin Liu; Joseph O'Neill; Tieqiao Liu; Wei Hao; Yanhui Liao
Journal:  J Psychiatry Neurosci       Date:  2022-07-26       Impact factor: 5.699

2.  The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study.

Authors:  Ellis Chika Onwordi; Thomas Whitehurst; Ayla Mansur; Ben Statton; Alaine Berry; Marina Quinlan; Declan P O'Regan; Maria Rogdaki; Tiago Reis Marques; Eugenii A Rabiner; Roger N Gunn; Anthony C Vernon; Sridhar Natesan; Oliver D Howes
Journal:  Transl Psychiatry       Date:  2021-07-17       Impact factor: 6.222

3.  Relationship between depression, prefrontal creatine and grey matter volume.

Authors:  Paul Faulkner; Susanna Lucini Paioni; Petya Kozhuharova; Natasza Orlov; David J Lythgoe; Yusuf Daniju; Elenor Morgenroth; Holly Barker; Paul Allen
Journal:  J Psychopharmacol       Date:  2021-10-26       Impact factor: 4.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.